NYSE$HI
Hillenbrand Inc · Q3 2021 earnings
Q3 2021 earnings · · Investor relations
Briefing
Hillenbrand had a strong quarter with exceptional cash generation and record backlog due to continued momentum in its industrial businesses, and Batesville performed better than expected.
Hillenbrand's Q3 2021 results showed a 14% increase in revenue to $695 million, driven by growth in Molding Technology Solutions. GAAP EPS increased by 66% to $0.53, and adjusted EPS rose by 5% to $0.85. The company's total backlog reached a record $1.77 billion, a 57% increase year over year. Cash flow from operations increased to $184 million, and net leverage decreased to 1.4x.
- Revenue of $695 million increased 14% year over year, with pro forma revenue up 18%.
- GAAP EPS of $0.53 increased 66% compared to the prior year, and adjusted EPS of $0.85 increased 5%.
- Record total backlog of $1.77 billion increased 57% year over year, or 62% on a pro forma basis.
- Cash flow from operations of $184 million increased $109 million compared to the prior year.
Headline financials
Revenue & EPS history
Hillenbrand · Revenue · Quarterly
$695M
Revenue by segment
Hillenbrand · $557M total across 2 segments · Q3 2021
- Advanced Process Solutions$313M—56.2%
- Molding Technology Solutions$244M—43.8%
Forward guidance
The Company’s outlook assumes a continued gradual stabilization of the global economy and no significant increase in pandemic-related disruptions to the Company’s businesses.
Tailwinds
- Total quarterly revenue is expected to be between $713 and $738 million, an increase of 6% to 9% year over year on a pro forma basis, which excludes Red Valve and ABEL
- Advanced Process Solutions revenue is expected to be between $340 and $350 million, an increase of 9% to 12% on a pro forma basis, which excludes Red Valve and ABEL
- Molding Technology Solutions revenue is expected to be between $238 and $250 million, an increase of 10% to 15%
- Adjusted EPS is expected to be in the range of $0.82 to $0.92
Headwinds
- Continued uncertainties related to the COVID-19 pandemic, including pandemic duration, severity and resurgence in various parts of the world
- Vaccine availability and effectiveness
- Supply chain disruptions
- Other effects
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 8 quarterly earnings reports
-0.6%
Avg return
Earnings day
-0.9%
Avg return
5 days after
-3.7%
Avg return
30 days after
45%
29 / 64 earnings
Positive
+18.5%
Q3 2025
Best reaction
-16.3%
Q2 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q2 2026 | — | — | — | |
| Q1 2026 | — | — | — | |
| Q4 2025 | +0.0% | +0.3% | +0.1% | |
| Q3 2025 | +18.5% | +26.8% | +29.6% | |
| Q2 2025 | -10.6% | -9.5% | -13.8% | |
| Q1 2025 | -7.3% | +1.1% | -18.7% | |
| Q4 2024 | +9.8% | +5.3% | +4.9% | |
| Q3 2024 | -6.9% | -14.0% | -25.7% | |
| Q2 2024 | -16.3% | -14.5% | -7.4% | |
| Q1 2024 | -6.6% | -2.6% | +1.1% | |
| Q4 2023 | -3.6% | — | — | |
| Q3 2023 | -6.3% | — | — | |
| Q2 2023 | -4.5% | — | — | |
| Q1 2023 | -6.1% | — | — | |
| Q4 2022 | +6.0% | — | — | |
| Q3 2022 | -0.1% | — | — | |
| Q2 2022 | -4.2% | — | — | |
| Q1 2022 | +0.8% | — | — | |
| Q4 2021 | +0.5% | — | — | |
| Q3 2021 | +0.7% | — | — | |
| Q2 2021 | -7.2% | — | — | |
| Q1 2021 | +0.1% | — | — | |
| Q4 2020 | +0.3% | — | — | |
| Q3 2020 | +6.5% | — | — | |
| Q2 2020 | +1.6% | — | — | |
| Q1 2020 | -2.1% | — | — | |
| Q4 2019 | -1.8% | — | — | |
| Q3 2019 | -7.3% | — | — | |
| Q2 2019 | -5.8% | — | — | |
| Q1 2019 | +6.5% | — | — | |
| Q4 2018 | -2.8% | — | — | |
| Q3 2018 | +4.0% | — | — | |
| Q2 2018 | -5.3% | — | — | |
| Q1 2018 | +2.6% | — | — | |
| Q4 2017 | +9.0% | — | — | |
| Q3 2017 | +0.4% | — | — | |
| Q2 2017 | +3.1% | — | — | |
| Q1 2017 | -3.1% | — | — | |
| Q4 2016 | +2.7% | — | — | |
| Q3 2016 | -0.7% | — | — | |
| Q2 2016 | -0.6% | — | — | |
| Q1 2016 | -6.4% | — | — | |
| Q4 2015 | -1.1% | — | — | |
| Q3 2015 | +5.7% | — | — | |
| Q2 2015 | +10.5% | — | — | |
| Q1 2015 | -6.4% | — | — | |
| Q4 2014 | +1.6% | — | — | |
| Q3 2014 | +1.4% | — | — | |
| Q2 2014 | -2.0% | — | — | |
| Q1 2014 | +7.0% | — | — | |
| Q4 2013 | +2.7% | — | — | |
| Q3 2013 | -1.1% | — | — | |
| Q2 2013 | -2.6% | — | — | |
| Q1 2013 | -1.0% | — | — | |
| Q4 2012 | +1.6% | — | — | |
| Q3 2012 | +2.1% | — | — | |
| Q2 2012 | +1.4% | — | — | |
| Q1 2012 | +0.0% | — | — | |
| Q4 2011 | +7.0% | — | — | |
| Q3 2011 | -8.4% | — | — | |
| Q2 2011 | -0.9% | — | — | |
| Q1 2011 | -0.7% | — | — | |
| Q4 2010 | -4.7% | — | — | |
| Q3 2010 | -4.8% | — | — | |
| Q3 2009 | -4.8% | — | — | |
| Q2 2010 | +1.6% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro